Advertisement
Advertisement
ESPR
Esperion Therapeutics, Inc.
2.17
USDSponsored
-0.01
-0.23%
Apr 10, 15:59 UTC -4
Closed
After-Market
2.19
+0.02
+0.69%
Esperion Therapeutics, Inc. Financial Snapshot
| Market Cap | 562.41M |
| Beta | 1.17 |
| Earnings Per Share (EPS) | -0.17 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -3.66% |
| Total Debt/Equity (D/E) | -82.62% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 1.54% |
| Free Cash Flow | -13.09M |
Trending Stocks
Advertisement